"

From 2012.igem.org

Revision as of 11:25, 7 June 2012 (view source) Fred (Talk | contribs) ← Older edit		Revision as of 11:29, 7 June 2012 (view source) Fred (Talk | contribs) Newer edit →
Line 5:		Line 5:
	|}		|}
-	{|align="justify"
-	|Coming soon...
-	|}
		+	==<span style="color:#2244AA">  Overall project ==
		+	Since April 2012, we are working in the field of so called TAL effectors in our lab. TAL effectors are molecular machines that are fused to DNA binding proteins in order to restrict their acticvity to specific loci in a genome. In particular, we develop a strategy to cheaply create novel TAL effectors in an extremely short period of time. This new method will enable us to test numerous novel effectors in human cells and to assess their therapeutic potential for genetic diseases, epigenetic alterations and cancer.
-	== '''Overall project''' ==
-	Tell us more about your project.  Give us background.  Use this is the abstract of your project.  Be descriptive but concise (1-2 paragraphs)
		+	== <span style="color:#2244AA"> Project Details==
Line 25:		Line 23:
-	== Project Details==	+	==== <span style="color:#2244AA"> Part 2 ====
Line 31:		Line 29:
-	=== Part 2 ===	+	=== <span style="color:#2244AA"> The Experiments ===
		+	=== <span style="color:#2244AA"> Part 3 ===
-	=== The Experiments ===
		+	== <span style="color:#2244AA"> Results ==
-	=== Part 3 ===
-		+	== <span style="color:#2244AA"> Promote Synthetic Biology ==
-	== Results ==	+

---

Revision as of 11:29, 7 June 2012

Contents 1 Overall project 2 Project Details 2.1 Part 2 2.2 The Experiments 2.3 Part 3 3 Results 4 Promote Synthetic Biology

Overall project

Since April 2012, we are working in the field of so called TAL effectors in our lab. TAL effectors are molecular machines that are fused to DNA binding proteins in order to restrict their acticvity to specific loci in a genome. In particular, we develop a strategy to cheaply create novel TAL effectors in an extremely short period of time. This new method will enable us to test numerous novel effectors in human cells and to assess their therapeutic potential for genetic diseases, epigenetic alterations and cancer.

Project Details

Part 2

The Experiments

Part 3

Results

Promote Synthetic Biology

Home	Team	Official Team Profile	Project	Parts Submitted to the Registry	Modeling	Notebook	Safety	Attributions